+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 181 Pages
  • Global
From
Therapeutic Injectable Drugs - Devices, Products and Markets - Product Thumbnail Image

Therapeutic Injectable Drugs - Devices, Products and Markets

  • Report
  • June 2023
  • 235 Pages
  • Global
From
Congenital Diaphragmatic Hernia Drugs Market Report 2025 - Product Thumbnail Image

Congenital Diaphragmatic Hernia Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Chronic Lymphocytic Leukemia- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Lymphocytic Leukemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 210 Pages
  • Global
From
From
From
From
From
From
From
Antibody Drug Conjugates Market Report 2025-2035 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025-2035

  • Report
  • December 2024
  • 342 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
From
Loading Indicator